Bunge Global SA (NYSE:BG – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $132.6667.
A number of research firms have commented on BG. BMO Capital Markets boosted their price objective on Bunge Global from $135.00 to $150.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 31st. UBS Group reaffirmed a “buy” rating on shares of Bunge Global in a report on Wednesday, March 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Bunge Global in a report on Friday, May 22nd. JPMorgan Chase & Co. upped their price objective on Bunge Global from $130.00 to $134.00 and gave the stock an “overweight” rating in a report on Tuesday, March 24th. Finally, Morgan Stanley upped their price objective on Bunge Global from $130.00 to $140.00 and gave the stock an “overweight” rating in a report on Wednesday, March 11th.
Get Our Latest Analysis on Bunge Global
Bunge Global Price Performance
Bunge Global (NYSE:BG – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The basic materials company reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.86. The company had revenue of $21.86 billion for the quarter, compared to analyst estimates of $23.38 billion. Bunge Global had a return on equity of 8.60% and a net margin of 0.85%.The business’s revenue was up 87.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 earnings per share. Bunge Global has set its FY 2026 guidance at 9.000-9.500 EPS. Equities research analysts forecast that Bunge Global will post 9.57 earnings per share for the current fiscal year.
Bunge Global Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 2nd. Shareholders of record on Tuesday, February 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, February 16th. This represents a $2.88 annualized dividend and a yield of 2.6%. Bunge Global’s dividend payout ratio is currently 67.13%.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. Foster Dykema Cabot & Partners LLC acquired a new position in shares of Bunge Global in the 3rd quarter valued at $25,000. Quest 10 Wealth Builders Inc. acquired a new position in shares of Bunge Global in the 4th quarter valued at $27,000. CYBER HORNET ETFs LLC bought a new position in Bunge Global during the 2nd quarter worth about $31,000. MUFG Securities EMEA plc bought a new position in Bunge Global during the 2nd quarter worth about $32,000. Finally, Stance Capital LLC bought a new position in Bunge Global during the 3rd quarter worth about $34,000. Institutional investors and hedge funds own 86.23% of the company’s stock.
Bunge Global Company Profile
Bunge Global is a leading agribusiness and food company that processes oilseeds and grains, produces sugar and bioenergy, and supplies fertilizers and other agricultural inputs. The company operates an integrated value chain that spans origination, processing, and distribution, enabling it to serve food processors, livestock producers, and retail customers worldwide. Through its network of processing plants, port terminals and logistics assets, Bunge handles a diverse portfolio of commodities, including soybeans, corn, wheat, vegetable oils, and sugarcane.
The company’s core business activities are organized into agribusiness and food & ingredients segments.
Read More
- Five stocks we like better than Bunge Global
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Bunge Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunge Global and related companies with MarketBeat.com's FREE daily email newsletter.
